Overall rank by patents
#24,632
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, active 2016–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
KOCH holds 11 US patents across 7 technology areas, rank #24,632 of 50,000 tracked assignees.
KOCH Biological Solutions, Llc has been granted 11 US utility patents between 2016 and 2019, placing KOCH Biological Solutions, Llc at rank #24,632 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.6 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, KOCH Biological Solutions, Llc is one of the more focused assignees in the PatentsView dataset. By volume, KOCH sits between Klatu Networks, Inc. (11 patents, rank #24,628) and KONI B.v. (11 patents, rank #24,636) - the closest US assignees by grant volume. The composite Innovation Score of 24.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 11 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. KOCH Biological Solutions, Llc's 11.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark KOCH Biological Solutions, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
KLATU Networks, Inc.
11 patents
KMC CHAIN INDUSTRIAL CO., LTD.
11 patents
KNO2 LLC
11 patents
KNOW SYSTEMS CORP
11 patents
KOJIMA PRESS INDUSTRY CO., LTD.
11 patents
KOMICO LTD.
11 patents
KONGJU NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
11 patents
KONI B.V.
11 patents
KOCH BIOLOGICAL SOLUTIONS, LLC
11 patents
What this shows KOCH holds 11 patents at rank #24,632, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
KOCH's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 84% higher than 16% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 9.1% |
| 2017 | 2 | 18.2% |
| 2018 | 3 | 27.3% |
| 2019 | 5 | 45.5% |
Top 7 of 7 technology areas
Overall rank by patents
#24,632
Across all tracked assignees
24.9 out of 100
How to use this portfolio
KOCH's 11 grants land it in the top 84% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.